Hikal has informed that the meeting of the Board of Directors of the Company will be held on May 06, 2016, to consider, approve and to take on record the Audited Financial Results of the Company for the year ended March 31, 2016. Further, pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 the Trading Window for trading in the shares of the Company will be closed for Promoters, Directors and Designated Persons of the Company from April 28, 2016 to May 08, 2016 for consideration of Audited Financial Results for the year ended March 31, 2016.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: